<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Proven GORD – One‑Page Clinical Algorithm</title>
  <style>
    /* ===== Base ===== */
    :root{
      --bg:#f9fafb;           /* light, no dark mode */
      --panel:#ffffff;
      --ink:#0f172a;          /* slate-900 */
      --muted:#475569;        /* slate-600 */
      --brand:#2563eb;        /* blue-600 */
      --brand-weak:#dbeafe;   /* blue-100 */
      --accent:#0ea5e9;       /* sky-500 */
      --ok:#059669;           /* emerald-600 */
      --warn:#b45309;         /* amber-700 */
      --danger:#b91c1c;       /* red-700 */
      --border:#e5e7eb;       /* gray-200 */
    }
    html,body{height:100%;}
    body{
      margin:0;
      font-family: ui-sans-serif, system-ui, -apple-system, Segoe UI, Roboto, Helvetica, Arial, "Apple Color Emoji", "Segoe UI Emoji";
      color:var(--ink);
      background:var(--bg);
      -webkit-print-color-adjust: exact; print-color-adjust: exact;
    }
    h1,h2,h3{margin:0 0 .5rem}
    h1{font-size:clamp(1.4rem,2.2vw,2rem); letter-spacing:.2px}
    h2{font-size:1rem; text-transform:uppercase; letter-spacing:.08em; color:var(--muted)}
    h3{font-size:1.05rem}
    p{margin:.25rem 0 .5rem}
    small{color:var(--muted)}

    /* ===== Header ===== */
    .header{
      position:sticky; top:0; z-index:10;
      background:linear-gradient(180deg, #fff 0%, #fff 75%, rgba(255,255,255,0.85) 100%);
      border-bottom:1px solid var(--border);
      backdrop-filter:saturate(180%) blur(6px);
    }
    .header-inner{max-width:1100px; margin:0 auto; padding:.9rem 1.2rem; display:flex; align-items:center; gap:1rem}
    .badge{background:var(--brand-weak); color:var(--brand); padding:.25rem .5rem; border-radius:999px; font-weight:600; font-size:.75rem}
    .title{display:flex; flex-direction:column}
    .title h1{font-weight:800}
    .sub{font-size:.85rem; color:var(--muted)}

    /* ===== Layout ===== */
    .page{max-width:1100px; margin:1rem auto 2rem; padding:0 1.2rem}
    .grid{display:grid; gap:1rem}
    .grid.cols{
      grid-template-columns:repeat(12, 1fr);
    }
    .card{
      background:var(--panel); border:1px solid var(--border); border-radius:18px;
      padding:1rem 1rem 1.1rem; box-shadow:0 1px 0 rgba(15,23,42,.04), 0 10px 20px -12px rgba(2,6,23,0.06);
    }
    .card h3{font-weight:700}
    .tag{display:inline-flex; align-items:center; gap:.35rem; font-size:.75rem; font-weight:600; color:var(--brand); background:var(--brand-weak); padding:.2rem .5rem; border-radius:999px}

    /* ===== Flow ===== */
    .flow{display:grid; grid-template-columns:repeat(6,1fr); gap:.75rem; margin:1rem 0}
    .step{background:#ffffff; border:1px solid var(--border); border-radius:14px; padding:.7rem .8rem}
    .step .k{font-size:.7rem; font-weight:700; color:var(--muted); text-transform:uppercase; letter-spacing:.06em}
    .step .v{font-weight:800}
    .arrow{display:flex; align-items:center; justify-content:center}
    .arrow svg{width:22px;height:22px}

    /* ===== Lists & pills ===== */
    .pill{display:inline-block; border:1px solid var(--border); border-radius:999px; padding:.2rem .6rem; margin:.15rem .25rem .15rem 0; font-size:.8rem}
    .bullets{margin:.4rem 0 .2rem; padding-left:1.1rem}
    .bullets li{margin:.2rem 0}

    /* ===== Tables ===== */
    table{width:100%; border-collapse:separate; border-spacing:0; font-size:.92rem}
    th,td{padding:.55rem .6rem; text-align:left}
    thead th{position:sticky; top:64px; background:#f3f6ff; color:#1e293b; border-bottom:1px solid var(--border)}
    tbody tr:nth-child(even){background:#fafafa}
    tbody tr{border-bottom:1px solid var(--border)}
    .tbl-note{font-size:.8rem; color:var(--muted); margin-top:.4rem}

    /* ===== Callouts ===== */
    .callout{border-left:4px solid var(--accent); background:#f0f9ff; padding:.7rem .9rem; border-radius:12px}
    .danger{border-left-color: #fecaca; background:#fff7f7}
    .danger .call-title{color:var(--danger)}
    .ok{border-left-color:#bbf7d0; background:#f0fdf4}
    .ok .call-title{color:var(--ok)}
    .call-title{font-weight:800; margin-bottom:.25rem}

    /* ===== Footer ===== */
    footer{margin-top:1rem; color:var(--muted); font-size:.8rem}

    /* ===== Print (A4 one‑pager) ===== */
    @page{size:A4; margin:10mm}
    @media print{
      .header{position:static; backdrop-filter:none}
      thead th{top:auto}
      .page{margin:0; padding:0}
      .card{box-shadow:none}
      .flow{gap:.5rem}
    }
  </style>
</head>
<body>
  <!-- Header -->
  <header class="header" role="banner">
    <div class="header-inner">
      <div class="badge" aria-label="Topic">One‑Page Algorithm</div>
      <div class="title">
        <h1>Proven GORD — Primary Care (Adults ≥18y)</h1>
        <div class="sub">Fast reference for consultations · Use with clinical judgment</div>
      </div>
    </div>
  </header>

  <main class="page" role="main">
    <!-- Top flow overview -->
    <section aria-labelledby="flow" class="card">
      <h2 id="flow">At‑a‑Glance Flow</h2>
      <div class="flow" aria-label="Algorithm overview">
        <div class="step">
          <div class="k">Step 1</div>
          <div class="v">Assess</div>
          <small>Red flags · Meds · OTC use</small>
        </div>
        <div class="arrow" aria-hidden="true">
          <svg viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M5 12h14M13 6l6 6-6 6" stroke="#2563eb" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"/></svg>
        </div>
        <div class="step">
          <div class="k">Step 2</div>
          <div class="v">Lifestyle</div>
          <small>Weight · Triggers · Bed head ↑</small>
        </div>
        <div class="arrow" aria-hidden="true">
          <svg viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M5 12h14M13 6l6 6-6 6" stroke="#2563eb" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"/></svg>
        </div>
        <div class="step">
          <div class="k">Step 3</div>
          <div class="v">PPI</div>
          <small>Full dose 4–8 wks</small>
        </div>
        <div class="arrow" aria-hidden="true">
          <svg viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M5 12h14M13 6l6 6-6 6" stroke="#2563eb" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"/></svg>
        </div>
        <div class="step">
          <div class="k">Step 4</div>
          <div class="v">If Persistent</div>
          <small>Double PPI · H2RA · Switch</small>
        </div>
        <div class="arrow" aria-hidden="true">
          <svg viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M5 12h14M13 6l6 6-6 6" stroke="#2563eb" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"/></svg>
        </div>
        <div class="step">
          <div class="k">Step 5</div>
          <div class="v">Maintain</div>
          <small>Lowest effective dose</small>
        </div>
      </div>
      <div class="callout danger" role="note">
        <div class="call-title">Urgent 2‑week endoscopy referral</div>
        <div>Any <strong>dysphagia</strong>, or <strong>age ≥55 with weight loss</strong>, or persistent unexplained dyspepsia/reflux.</div>
      </div>
    </section>

    <!-- Grid sections -->
    <section class="grid cols" style="margin-top:1rem">
      <!-- 1. Initial Assessment -->
      <article class="card" style="grid-column: span 6" aria-labelledby="sec1">
        <h2 id="sec1">1 · Initial Assessment</h2>
        <ul class="bullets">
          <li>Screen for <strong>alarm symptoms</strong> (see red box above).</li>
          <li>Review medicines that aggravate reflux: <span class="pill">NSAIDs</span><span class="pill">CCBs</span><span class="pill">Nitrates</span><span class="pill">TCAs</span><span class="pill">Anticholinergics</span><span class="pill">Benzodiazepines</span><span class="pill">Bisphosphonates</span> etc.</li>
          <li>Ask about <strong>OTC antacids/alginates</strong> used.</li>
        </ul>
      </article>

      <!-- 2. Lifestyle -->
      <article class="card" style="grid-column: span 6" aria-labelledby="sec2">
        <h2 id="sec2">2 · Lifestyle & Self‑Care</h2>
        <ul class="bullets">
          <li>Weight loss if overweight/obese.</li>
          <li>Avoid triggers: coffee, chocolate, tomatoes, fatty/spicy foods; smaller meals; avoid food 3–4h pre‑bed.</li>
          <li>Raise head of bed by 10–20 cm (blocks), <em>not</em> extra pillows.</li>
          <li>Stop smoking; reduce alcohol; address stress/anxiety.</li>
        </ul>
        <div class="callout ok"><div class="call-title">Education</div>Provide written info on GORD and self‑care; agree follow‑up plan.</div>
      </article>

      <!-- 3. Pharmacological -->
      <article class="card" style="grid-column: span 7" aria-labelledby="sec3">
        <h2 id="sec3">3 · Pharmacological Management</h2>
        <h3>Proven GORD (endoscopy confirmed)</h3>
        <ul class="bullets">
          <li><strong>PPI full dose × 4 weeks</strong> (for healing).</li>
          <li>If <strong>severe oesophagitis</strong>: full‑dose <strong>8 weeks</strong> then <strong>long‑term maintenance</strong>.</li>
          <li><strong>Do not test</strong> for <em>H. pylori</em>.</li>
        </ul>
      </article>

      <!-- 4. Refractory -->
      <article class="card" style="grid-column: span 5" aria-labelledby="sec4">
        <h2 id="sec4">4 · If Symptoms Recur / Persist</h2>
        <ul class="bullets">
          <li>Reassess for new red flags; check adherence & lifestyle.</li>
          <li>Options (1 month each unless stated):</li>
        </ul>
        <ul class="bullets" style="margin-left:.5rem">
          <li>Repeat <strong>full‑dose PPI</strong>.</li>
          <li><strong>Double‑dose PPI</strong>.</li>
          <li>Add <strong>H<sub>2</sub>RA at bedtime</strong> (short intermittent course, e.g., 2 weeks) for nocturnal symptoms.</li>
          <li>For <em>endoscopy‑negative reflux</em>: consider <strong>H<sub>2</sub>RA switch</strong> for 1 month.</li>
        </ul>
      </article>

      <!-- 5. Maintenance -->
      <article class="card" style="grid-column: span 6" aria-labelledby="sec5">
        <h2 id="sec5">5 · Long‑Term Maintenance</h2>
        <ul class="bullets">
          <li><strong>Annual review</strong> if on long‑term therapy.</li>
          <li>Encourage <strong>step‑down/stop</strong> if suitable; or use <strong>lowest effective PPI dose</strong> / <strong>PRN</strong>.</li>
          <li>Self‑treatment with antacid/alginate PRN (not continuous long‑term).</li>
          <li><strong>Do not step down</strong> if: severe/complicated oesophagitis, Barrett’s, NSAID gastroprotection, or prior bleeding ulcer with persistent <em>H. pylori</em>.</li>
        </ul>
      </article>

      <!-- 6. Referral -->
      <article class="card" style="grid-column: span 6" aria-labelledby="sec6">
        <h2 id="sec6">6 · When to Refer</h2>
        <ul class="bullets">
          <li>Symptoms <strong>refractory</strong>, persistent or unexplained despite optimized therapy.</li>
          <li>Responds to PPI but <strong>not tolerated</strong> / patient declines long‑term therapy.</li>
          <li>Risk factors for <strong>Barrett’s</strong>: male, long duration/frequency of reflux, hiatus hernia, prior stricture/ulcers → consider endoscopy.</li>
          <li>Considering anti‑reflux surgery.</li>
        </ul>
      </article>

      <!-- 7. Specialist -->
      <article class="card" style="grid-column: span 5" aria-labelledby="sec7">
        <h2 id="sec7">7 · Specialist (for info)</h2>
        <h3>Investigations</h3>
        <ul class="bullets">
          <li>24‑h oesophageal pH monitoring (symptom correlation).</li>
          <li>Oesophageal manometry (exclude motility disorders; pre‑surgery).</li>
          <li>Barium swallow/meal (structural & motility assessment).</li>
        </ul>
        <h3>Management</h3>
        <ul class="bullets">
          <li>Laparoscopic fundoplication (gold standard; counsel risks: gas‑bloat, dysphagia, stricture, recurrence; small mortality risk).</li>
          <li>Other options in specialist centres: endoscopic radiofrequency, magnetic bead band, bulking agents.</li>
        </ul>
      </article>

      <!-- 8. Prescribing quick ref -->
      <article class="card" style="grid-column: span 7" aria-labelledby="sec8">
        <h2 id="sec8">8 · Prescribing Quick Reference</h2>
        <h3>Proton Pump Inhibitors (PPIs)</h3>
        <table aria-label="PPI dosing table">
          <thead>
            <tr>
              <th style="width:28%">PPI</th>
              <th>Full/Standard Dose</th>
              <th>Double Dose</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>Omeprazole</td>
              <td>20 mg OD (40 mg OD if severe)</td>
              <td>40 mg OD (40 mg BD if severe)</td>
            </tr>
            <tr>
              <td>Lansoprazole</td>
              <td>30 mg OD</td>
              <td>30 mg BD</td>
            </tr>
            <tr>
              <td>Pantoprazole</td>
              <td>40 mg OD</td>
              <td>40 mg BD</td>
            </tr>
            <tr>
              <td>Rabeprazole</td>
              <td>20 mg OD</td>
              <td>20 mg BD</td>
            </tr>
            <tr>
              <td>Esomeprazole</td>
              <td>20 mg OD (40 mg OD if severe)</td>
              <td>40 mg OD (40 mg BD if severe)</td>
            </tr>
          </tbody>
        </table>
        <p class="tbl-note"><strong>Timing:</strong> give 30 min before breakfast (and before evening meal if twice daily) for optimal pH control. Doses in brackets for severe oesophagitis. Some doses off‑label for GORD.</p>

        <h3 style="margin-top:.8rem">H<sub>2</sub>‑Receptor Antagonists</h3>
        <table aria-label="H2RA dosing table">
          <thead>
            <tr>
              <th style="width:28%">H<sub>2</sub>RA</th>
              <th>Usual Treatment Dose</th>
              <th>Nocturnal Dose</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>Famotidine</td>
              <td>20–40 mg BD</td>
              <td>—</td>
            </tr>
            <tr>
              <td>Nizatidine</td>
              <td>150–300 mg BD</td>
              <td>—</td>
            </tr>
            <tr>
              <td>Ranitidine*</td>
              <td>150 mg BD</td>
              <td>300 mg ON</td>
            </tr>
          </tbody>
        </table>
        <p class="tbl-note">*Ranitidine currently unavailable in the UK and many regions.</p>
      </article>
    </section>

    <!-- Safety & interactions compact -->
    <section class="card" style="margin-top:1rem" aria-labelledby="safety">
      <h2 id="safety">Safety Pointers (Compact)</h2>
      <div style="display:grid; grid-template-columns:repeat(3,1fr); gap:.8rem">
        <div class="callout">
          <div class="call-title">PPIs — Cautions</div>
          <ul class="bullets">
            <li>Stop 2 weeks before endoscopy (may mask malignancy).</li>
            <li>Consider bone health (osteoporosis risk), magnesium monitoring if at risk.</li>
            <li>Long‑term rare risks: hypomagnesaemia, fractures, <em>C. difficile</em>, rebound acid.</li>
          </ul>
        </div>
        <div class="callout">
          <div class="call-title">Key Interactions</div>
          <ul class="bullets">
            <li><strong>Clopidogrel</strong>: avoid with omeprazole/esomeprazole.</li>
            <li>Warfarin/Phenytoin/Digoxin: monitor if starting/stopping certain PPIs.</li>
            <li>Protease inhibitors, azole antifungals: seek advice / adjust.</li>
          </ul>
        </div>
        <div class="callout">
          <div class="call-title">H<sub>2</sub>RAs — Notes</div>
          <ul class="bullets">
            <li>Hold 2 weeks pre‑endoscopy.</li>
            <li>Renal dose adjustments (famotidine, nizatidine).</li>
            <li>Adverse effects uncommon; CNS effects rare.</li>
          </ul>
        </div>
      </div>
    </section>

    <footer>
      Last updated for clinic use · Print to A4 for a single‑page handout. This quick reference summarizes guidance for <em>dyspepsia – proven GORD</em> in adults.
    </footer>
  </main>
</body>
</html>
